Myeloproliferative diseases (CML excluded)

No definition available.

Endpoint definition

↥
FinnGen phenotype data

Filter registries None

Check pre-conditions None

diagram bullet diagram downward connector

Check conditions

not CML

Apply sex-specific rule None

diagram downward connector MYELOPROF_NONCML

Extra metadata

First used in FinnGen datafreeze DF2, additional

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 952 514 438
Unadjusted prevalence (%) 0.37 0.35 0.39
Mean age at first event (years) 60.39 59.73 61.18

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.06 3.92 [2.48, 6.20] 4.8e-9 145
15 years 0.03 4.41 [2.85, 6.82] 2.7e-11 135
5 years 0.01 6.16 [3.93, 9.66] 2.2e-15 67
1 year - - - -

Correlations

↥

Index endpoint: MYELOPROF_NONCML – Myeloproliferative diseases (CML excluded)
GWS hits: 8

Survival analyses between endpoints

↥

Plot

before Myeloproliferative diseases (CML excluded)
after Myeloproliferative diseases (CML excluded)

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Myeloproliferative diseases (CML excluded)

↥